» Articles » PMID: 24678425

Simple and Sensitive Analysis of Blonanserin and Blonanserin C in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry and Its Application

Overview
Publisher Wiley
Specialty Chemistry
Date 2014 Mar 29
PMID 24678425
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

A highly sensitive, simple, and rapid liquid chromatography tandem mass spectrometry method to simultaneously determine blonanserin and blonanserin C in human plasma with AD-5332 as internal standard (IS) was established. A simple direct protein precipitation method was used for the sample pretreatment, and chromatographic separation was performed on a Waters XBridge C8 (4.6 × 150 mm, 3.5  μ m) column. The mobile phase consists of a mixture of 10 mM ammonium formate and 0.1% formic acid in water (A) and 0.1% formic acid in methanol (B). To quantify blonanserin, blonanserin C, and IS, multiple reaction monitoring (MRM) was performed in positive ESI mode. The calibration curve was linear in the concentration range of 0.012-5.78 ng·mL(-1) for blonanserin and 0.023-11.57 ng·mL(-1) for blonanserin C (r (2) > 0.9990). The intra- and interday precision of three quality control (QC) levels in plasma were less than 7.5%. Finally, the current simple, sensitive, and accurate LC-MS/MS method was successfully applied to investigate the pharmacokinetics of blonanserin and blonanserin C in healthy Chinese volunteers.

Citing Articles

A Simple and Sensitive HPLC-MS/MS Assay for the Quantitation of Blonanserin and N-Desethyl Blonanserin in Rat Plasma and Its Application to Pharmacokinetic Study.

Huang S, Li X, Wang Z, Lu H, Xiao T, Ni X J Anal Methods Chem. 2022; 2022:5914581.

PMID: 35433070 PMC: 9010218. DOI: 10.1155/2022/5914581.


Optimization of Extraction Conditions for Determination of Tiliroside in L. Flowers Using an LC-ESI-MS/MS Method.

Pieczykolan A, Pietrzak W, Nowak R, Pielczyk J, Lamacz K J Anal Methods Chem. 2019; 2019:9052425.

PMID: 30729060 PMC: 6343130. DOI: 10.1155/2019/9052425.

References
1.
Suzuki H, Gen K . The relationship between the plasma concentration of blonanserin, and its plasma anti-serotonin 5-HT(2A) activity/anti-dopamine D₂ activity ratio and drug-induced extrapyramidal symptoms. Psychiatry Clin Neurosci. 2012; 66(2):146-52. DOI: 10.1111/j.1440-1819.2011.02311.x. View

2.
Ochi T, Sakamoto M, Minamida A, Suzuki K, Ueda T, Une T . Syntheses and properties of the major hydroxy metabolites in humans of blonanserin AD-5423, a novel antipsychotic agent. Bioorg Med Chem Lett. 2005; 15(4):1055-9. DOI: 10.1016/j.bmcl.2004.12.028. View

3.
Garcia E, Robert M, Peris F, Nakamura H, Sato N, Terazawa Y . The efficacy and safety of blonanserin compared with haloperidol in acute-phase schizophrenia: a randomized, double-blind, placebo-controlled, multicentre study. CNS Drugs. 2009; 23(7):615-25. DOI: 10.2165/00023210-200923070-00006. View

4.
Wen Y, Ni X, Zhang M, Liu X, Shang D . Simultaneous determination of blonanserin and its metabolite in human plasma and urine by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2012; 903:46-52. DOI: 10.1016/j.jchromb.2012.06.037. View

5.
Zhou Y, Liu M, Jiang J, Wang H, Hu P . Simultaneous determination of blonanserin and its four metabolites in human plasma using ultra-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2013; 939:59-66. DOI: 10.1016/j.jchromb.2013.09.007. View